[topsearch__bar__shortcode]

December 2024

Sunshine Biopharma (SBFM) Shares Surge Following Key Drug Launch

Shares of Sunshine Biopharma, Inc. (NASDAQ: SBFM) are on a significant boost following the announcement of a new drug launch. As of the latest check, SBFM stock was priced at $3.37, reflecting its robust 13.47% increase on the US stock charts. This surge underscores investor optimism surrounding the company’s expanding portfolio and recent innovations. Launch […]

Sunshine Biopharma (SBFM) Shares Surge Following Key Drug Launch Read More »

QuantumScape (QS) Stock Rises Following Milestone Achievement

QuantumScape Corporation (NYSE: QS) stock is witnessing a 5.10% rise as of the last check today, reaching $5.15 following the announcement of a significant product development milestone. QS unveiled the successful development, delivery, and installation of Cobra, a next-generation heat treatment system for its separator production process. Cobra: A Breakthrough in Separator Technology The Cobra

QuantumScape (QS) Stock Rises Following Milestone Achievement Read More »

Protara (TARA) Stock Skyrockets After Promising Trial Results

After Protara Therapeutics, Inc. (NASDAQ: TARA) revealed encouraging results from its current Phase 2 ADVANCED-2 study, its shares jumped sharply, increasing more than 103% to $7.20. The study evaluates TARA-002, an experimental cell-based treatment, for the treatment of high-risk non-muscle invasive bladder cancer (NMIBC) in patients with carcinoma in situ (CIS), especially those who are

Protara (TARA) Stock Skyrockets After Promising Trial Results Read More »

Arcadia Biosciences (RKDA) Pre-Market Rally Linked To A Merger

The stock price of Arcadia Biosciences, Inc. (NASDAQ: RKDA) had a sharp increase during the pre-market trading session, increasing 153.74% to $7.13. The rise comes after Roosevelt Resources LP and the company announced a final securities exchange agreement. Arcadia will issue common stock to Roosevelt’s partners in return for all equity interests in Roosevelt as

Arcadia Biosciences (RKDA) Pre-Market Rally Linked To A Merger Read More »

Equity Move Boosts Cheer Holding (CHR) Stock Performance

Cheer Holding, Inc.’s (NASDAQ: CHR) new equity activities and creative endeavors are drawing market attention after a $50 million share repurchase program was announced. Following a rise of more than 6% the previous session, CHR shares increased 9.27% to $3.13 as of the most recent check. Repurchase Program for $50 Million Shares Over the next 36

Equity Move Boosts Cheer Holding (CHR) Stock Performance Read More »

Alterity (ATHE) Stock Gains Momentum With Key Clinical Trial Update

As of the most recent check, Alterity Therapeutics Limited’s (NASDAQ: ATHE) stock was up 36.09%, trading at $2.17 on the US stock charts. The news of a significant success in its ATH434-201 Phase 2 clinical study triggered the spike in ATHE shares. This milestone marks the completion of clinical evaluations for the last enrolled patient,

Alterity (ATHE) Stock Gains Momentum With Key Clinical Trial Update Read More »

AI Demand Propels Marvell Technology (MRVL) Stock Surge Post-Earnings

The US stock market is paying more attention to Marvell Technology, Inc. (NASDAQ: MRVL) after the company’s fiscal third-quarter 2025 earnings report was released. At $116.23 as of the most recent trading session, MRVL shares had increased 21.19%. MRVL exceeded the midpoint of their projection with a 19% sequential revenue growth, reaching $1.516 billion. Marvell

AI Demand Propels Marvell Technology (MRVL) Stock Surge Post-Earnings Read More »

Okta Shares Surge In After-Hour Trading Following Earnings Release

Following the release of its fiscal Q3 2025 earnings report, Okta, Inc. (NASDAQ: OKTA) shares experienced a notable surge on the US stock charts. During after-hours trading, shares climbed 15.53%, reaching $94.40. The surge was fueled by its robust financial performance, including a Non-GAAP net income of $121 million—an impressive increase from the $79 million

Okta Shares Surge In After-Hour Trading Following Earnings Release Read More »

Extended Session Boost For SeaStar (ICU) Amid Clinical Trial Advances

SeaStar Medical Holding Corporation (NASDAQ: ICU) announced significant advancements in its pivotal trial. The news sparked a 13.50% rise in ICU stock, sending its price to $2.69 during after-market trading on Tuesday. New Site Activation and Enrollment Milestone SeaStar Medical (ICU) has activated Sentara Norfolk General Hospital in Norfolk, Virginia, marking the thirteenth active site

Extended Session Boost For SeaStar (ICU) Amid Clinical Trial Advances Read More »